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ABSTRACT
Motivation: Numerous competing algorithms for prediction in high-
dimensional settings have been developed in the statistical and ma-
chine-learning literature. Learning algorithms and the prediction
models they generate are typically evaluated on the basis of cross-
validation error estimates in a few exemplary datasets. However, in
most applications, the ultimate goal of prediction modeling is to pro-
vide accurate predictions for independent samples obtained in differ-
ent settings. Cross-validation within exemplary datasets may not
adequately reflect performance in the broader application context.
Methods: We develop and implement a systematic approach to
‘cross-study validation’, to replace or supplement conventional
cross-validation when evaluating high-dimensional prediction models
in independent datasets. We illustrate it via simulations and in a col-
lection of eight estrogen-receptor positive breast cancer microarray
gene-expression datasets, where the objective is predicting distant
metastasis-free survival (DMFS). We computed the C-index for all pair-
wise combinations of training and validation datasets. We evaluate
several alternatives for summarizing the pairwise validation statistics,
and compare these to conventional cross-validation.
Results: Our data-driven simulations and our application to survival
prediction with eight breast cancer microarray datasets, suggest that
standard cross-validation produces inflated discrimination accuracy
for all algorithms considered, when compared to cross-study valid-
ation. Furthermore, the ranking of learning algorithms differs, suggest-
ing that algorithms performing best in cross-validation may be
suboptimal when evaluated through independent validation.
Availability: The survHD: Survival in High Dimensions package (http://
www.bitbucket.org/lwaldron/survhd) will be made available through
Bioconductor.
Contact: levi.waldron@hunter.cuny.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Cross-validation and related resampling methods are de facto
standard for ranking supervised learning algorithms. They
allow estimation of prediction accuracy using subsets of data
that have not been used to train the algorithms. This avoids
over-optimistic accuracy estimates caused by ‘re-substitution’.
This characteristic has been carefully discussed in Molinaro
et al. (2005), Baek et al. (2009) and Simon et al. (2011). It is
common to evaluate algorithms by estimating prediction accur-
acy via cross-validation for several datasets, with results sum-
marized across datasets to rank algorithms (Boulesteix, 2013;
Demsar, 2006). This approach recognizes possible variations in
the relative performances of learning algorithms across studies or
fields of application. However, it is not fully consistent with the
ultimate goal, in the development of models with biomedical
applications, of providing accurate predictions for fully inde-
pendent samples, originating from institutions and processed
by laboratories that did not generate the training datasets.
It has been observed that accuracy estimates of genomic pre-
diction models based on independent validation data are often
substantially inferior to cross-validation estimates (Castaldi et al.,
2011). In some cases this has been attributed to incorrect appli-
cation of cross-validation; however even strictly performed cross-
validation may not avoid over-optimism resulting from poten-
tially unknown sources of heterogeneity across datasets. These
include differences in design, acquisition and ascertainment stra-
tegies (Simon et al., 2009), hidden biases, technologies used for
measurements, and populations studied. In addition, many gen-
omics studies are affected by experimental batch effects (Baggerly
et al., 2008; Leek et al., 2010). Quantifying these heterogeneities
and describing their impact on the performance of prediction
algorithms is critical in the practical implementation of persona-
lized medicine procedures that use genomic information.
There are potentially conflicting, but valid, perspectives on
what constitutes a good learning algorithm. The first perspective
is that a good learning algorithm should perform well when
trained and applied to a single population and experimental set-
ting, but it is not expected to perform well when the resulting
model is applied to different populations and settings. We call
such an algorithm specialist, in the sense that it can adapt and
specialize to the population at hand. This is the mainstream per-
spective for assessing prediction algorithms and is consistent with
validation procedures performed within studies (Baek et al.,
2009; Molinaro et al., 2005; Simon et al., 2011). However, we
argue that it does not reflect the reality that ‘samples of conveni-
ence’ and uncontrolled specimen collection are the norm in gen-
omic biomarker studies (Simon et al., 2009).
We promote another perspective: a good learning algorithm
should be generalist, in the sense that it yields models that may be
suboptimal for the training population, or not fully representa-
tive of the dataset at hand, but that perform reasonably well
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across different populations and laboratories employing compar-
able but not identical methods. Generalist algorithms may be
preferable in important settings, for instance when a researcher
develops a model using samples from a highly controlled envir-
onment, but hopes the model to be applicable to other hospitals,
labs, or more heterogeneous populations.
In this article we systematically use independent validations
for the comparison of learning algorithms, in the context of
microarray data for disease-free survival of estrogen receptor-
positive breast cancer patients. Although concern has been
often expressed about the lack of independent validation of gen-
omic prediction models (Micheel et al., 2012; Subramanian and
Simon, 2010), independent validation has not been systematically
adopted in the comparison of learning algorithms. This defi-
ciency cannot be addressed for prediction contexts where related,
independent datasets are unavailable. For many cancer types,
however, several micro-array studies have been performed to
develop prognostic models. These datasets pave the way for a
systematic approach based on independent validations. For in-
stance, a recent meta-analysis of prognostic models for late-stage
ovarian cancer provides a comparison of publicly available
microarray datasets (Waldron et al., 2014). Furthermore,
Riester et al. (2014) showed that combining training datasets
can increase the accuracy of late-stage ovarian cancer risk
models. Thus situations exist in genomic data analysis where
comparable, independent datasets are available, and these pre-
sent an opportunity to use independent validation as an explicit
basis for assessing learning algorithms.
We propose what we term ‘leave-one-dataset-in’ cross-study
validation (CSV) to formalize the use of independent validations
in the evaluation of learning algorithms. Through data-driven
simulations, and an example involving eight publicly available
estrogen receptor-positive breast cancer microarray datasets, we
assess established survival prediction algorithms using our ‘leave-
one-dataset-in’ scheme and compare it to conventional cross-
validation.
2 METHODS
2.1 Notation and setting
>We consider multiple datasets i=1, . . . , I with sample sizes N1, . . . , NI.
Each observation s appears only in one dataset i, i.e. datasets do not over-
lap, and the corresponding record includes a primary outcome Ysi and a
vector of predictor variables Xsi ; throughout this article X
s
i will be gene-
expression measurements. Our goal is to compare the performance of dif-
ferent learning algorithms k=1, . . . , K that generates prediction models
for the primary outcome using the vector of predictors. Throughout this
article, the primary outcome is a possibly censored survival time.
We are interested in evaluating and ranking competing prediction
methods k=1, . . . , K. Since the ranking may depend on the application,
the first step is to define the prediction task of interest. We focus on the
prediction of metastasis-free survival time in breast cancer patients based
on high-throughput gene-expression measurements. Our approach and
the concept of CSV, however, can be applied to different types of re-
sponse variables and any other prediction task.
2.2 Algorithms
We assess six learning algorithms (k=1, . . . , 6) appropriate for high-
dimensional continuous predictors and possibly censored time-to-event
outcomes: Lasso and Ridge regression (Goeman, 2010), CoxBoost (Binder
and Schumacher, 2008), SuperPC (Blair and Tibshirani, 2004), Unicox
(Tibshirani, 2009) and Plusminus (Zhao et al., 2013). All parameters were
tuned either by default methods included in their implementation (Ridge
and Lasso regression: R-package glmnet) or by testing a range of param-
eters in internal cross-validation. Our focus is not to provide a compre-
hensive array of algorithms, but simply to use a few popular,
representative algorithms to investigate CSV.
2.3 CSV matrices
We refer in this article to m-fold cross-validation and related resampling
methods collectively as cross-validation (CV). Our ranking procedure for
learning algorithms is based on a square matrix Zk of scores
(k=1, . . . ,K). The (i, j) element in the matrix measures how well the
model produced by algorithm k trained on dataset i performs when
validated on dataset j. Since we consider K methods we end up with K
method-specific square matrices Z1; . . . ;ZK: We set the diagonal entries
of the matrices equal to performance estimates obtained with 4-fold CV
in each dataset. We will call Zk the CSV matrix.
Possible definitions for the Zki;j scores include the concordance index in
survival analysis (Harrell et al., 1996), the area under the operating char-
acteristic curve in binary classification problems, or the mean squared
distance between predicted and observed values in regression problems.
We use survival models and focus on a concordance index, the C-
index, which is a correlation measure (Gnen and Heller, 2005) between
survival times and the risk scores, such as linear combinations of the
predictors, provided by a prediction model. The heatmap in Figure 1A
displays the CSV matrix of C-statistics obtained through validation of
eight models trained on the studies in Table 1 with Ridge regression.
2.4 Summarization of a CSV matrix
In order to rank learning algorithms k=1, . . . , K, we summarize each
matrix Zk by a single score. We consider following two candidate
approaches.
(1) The Simple Average of all non-diagonal elements of the Zk matrix:
CSV=
X
i
X
i6¼j
Zki;j
IðI 1Þ :
(2) The Median or more generally a quantile of the non-diagonal
entries of Zk. Quantiles offer robustness to outlier values, and
the possibility to reduce the influence of those studies that are
consistently associated with poor validation scores, both when
used for training and validation, and independently of the learning
algorithm.
2.5 True global ranking
Throughout our analyses the score Zki;j is a random variable. First, studies
i and j can be seen as randomly drawn from a population of studies.
Second, observations within each study can be considered as randomly
drawn from the unknown and possibly different distributions Fi and Fj
underlying studies i and j. With this view of Zki;j as random variable, we
consider the theoretical counterparts of the empirical aggregating scores
(simple average and quantiles) described in Section 2.4 to summarize Zk.
The theoretical counterparts are the expected value or quantiles of each
Zki;j score, i 6¼ j; obtained by integrating the two levels of randomness that
we described. The true global ranking of the learning algorithms
k=1, . . . ,K is then defined by these expected values (or quantiles), one
for each algorithm. We will call the ranking global because it depends on
the super-population (Hartley and Sielken, 1975) and not which popula-
tions were sampled by the available datasets.
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The true global ranking can be considered as the estimation target of
evaluation procedures such as CV or CSV. In Section 2.7 we present the
design of a data-driven simulation study in which we can compute the
true ranking through Monte Carlo integration. This allows us to evaluate
and compare the ability of CV and CSV to recover the true global
ranking.
2.6 Datasets
We used a compendium of breast cancer microarray studies curated for
the meta-analysis of Haibe-Kains et al. (2012) and available as supple-
ment to their article. We selected all eight datasets (Table 1) for which
distant metastasis-free survival (DMFS), the most commonly available
time to event endpoint, as well as Estrogen Receptor (ER) status, were
available. These studies were generated with Affymetrix HGU
GeneChips HG-U133A, HG-U133B and HG-U133PLUS2. We con-
sidered exclusively ER-positive tumors. Of these datasets, only one origi-
nated from a population-based cohort (Schmidt et al., 2008). Four studies
considered only patients who did not receive hormone therapy or adju-
vant chemotherapy. Only four provided date ranges of patient recruit-
ment (Chin et al. 2006; Desmedt et al., 2007; Foekens et al., 2006;
Schmidt et al., 2008). Table 1 points also to important differences in
survival (for instance 3Q survival) that are not easily explicable based
on known characteristics of these studies. This variability in design stra-
tegies, reporting, as well as outcomes, highlights the prevalence of ‘sam-
ples of convenience’ in biomarker studies discussed by Simon et al. (2009).
Samples from dataset ST1 duplicated in dataset VDX were removed.
Expression of each gene was summarized using the probeset with
A B C
Fig. 1. CSV matrices Zk in simulated and experimental data for Ridge regression. (A) C-indices for training and validation on each pair of actual datasets
in Table 1. The diagonal of this matrix shows estimates obtained through 4-fold CV. (B) The heatmap for each pair of studies (i, j), the average C-index
when we fit Ridge regression on a simulated dataset generated by resampling gene expression data and censored time to event outcomes from the i-th
study in Table 1, and validate the resulting model on a simulated dataset generated by resampling study j. Computation of each diagonal element
averages over pairs of independent datasets obtained by resampling from the same study. The heatmaps strongly resemble each other. CAL and MSK
are outlier studies: cross-study C-index is 0.5 when they are used either for training or validation. The values of the arrays in (A) and (B) that involve
these two studies constitute the blue ‘bad performance’ cluster in (C) which contrast the C-indices obtained for study pairs ði; jÞ; i 6¼ j, on simulated data
(y-axis) and experimental data (x-axis). Pearson correlation is 0.9. The three plots illustrate similarity between our simulation model and the actual
datasets in Table 1
Table 1. Breast cancer microarray datasets curated by Haibe-Kains et al. (2012)
Number Name Adjuvant
therapy
Number
of patientsa
Number of ER+ 3Q survival
[mo.]
Median
follow-up [mo.]
Original
identifiersb
Reference
1 CAL Chemo, hormonal 118 75 42 82 CAL Chin et al. (2006)
2 MNZ none 200 162 120 94 MAINZ Schmidt et al. (2008)
3 MSK combination 99 57 76 82 MSK Minn et al. (2005)
4 ST1 hormonal 512a 507b 114 106 MDA5, TAM, VDX3 Foekens et al. (2006)
5 ST2 hormonal 517 325 126 121 EXPO, TAM Symmans et al. (2010)
6 TRB none 198 134 143 171 TRANSBIG Desmedt et al. (2007)
7 UNT none 133 86 151 105 UNT Sotiriou et al. (2006)
8 VDX none 344 209 44 107 VDX Minn et al. (2007)
Datasets acronyms: CAL, University of California, San Francisco and the California Pacific Medical Center (USA); MNZ, Mainz hospital (Germany); MSK, Memorial
Sloan-Kettering (United States). ST1 and ST2 are meta-datasets provided by Haibe-Kains et al. (2012), TRB denotes the TransBIG consortium dataset (Europe), UNT
denotes the cohort of untreated patients from the Oxford Radcliffe Hospital (UK), VDX=Veridex (the Netherlands). Number of ER+ is the number of patients classified as
Estrogen Receptor positive. 3Q survival indicates the empirical estimate of the 75-th percentile of the distribution of the survival times (in months). Median follow-up (in
months) is computed using the reverse Kaplan–Meier estimate to avoid under-estimation due to early deaths (Schemper and Smith, 1996). aNumbers shown are after removal
of samples duplicated in the dataset VDX. bDataset identifiers specified in Haibe-Kains et al. (2012).
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maximum mean (Miller et al., 2011). The 50% of genes with lowest
variance were removed. Subsequently, gene-expression values were
scaled by linear scaling of the 2.5 and 97.5% quantiles as described by
Haibe-Kains et al. (2012).
2.7 Simulation design
We simulate heterogeneous datasets with gene-expression profiles and
time to event outcomes from a joint probability model. We define the
model through a resampling procedure that we apply to the eight breast
cancer datasets in Table 1. The resampling scheme is a combination of
parametric and nonparametric bootstrap (Efron and Tibshirani, 1993).
The goal of our simulation study is to compare CV and CSV when used
for ranking and evaluation of competing learning algorithms. Here we
use resampling methods to iteratively simulate realistic ensembles of
breast cancer datasets from a hierarchical probability model that we
define using the actual datasets in Table 1. CV and CSV are then assessed
with respect to their ability to recover the true global ranking, which we
compute through Monte-Carlo integration.
We will quantify the ability to recover the ranking by using the
Kendall correlation between the true global ranking and the estimates
obtained with CV or CSV.
For b=1, . . . ,B=1000 iterations, we generate a collection of I=8
datasets as follows. First, we sample eight study labels with replacement
from the list of breast cancer studies in Table 1. This step only involves
simulations from a multinomial Mult(8,[1/8, . . . , 1/8]) distribution. We
resample the collection of study labels to capture variability in study
availability, and heterogeneity of study characteristics. Second, for each
of the eight randomly drawn labels, we sample N=150 patients from the
corresponding original dataset, with replacement. If a study is randomly
assigned to the j-th label, then each of the N=150 vectors of predictive
variables is directly sampped from the empirical distribution of the j-th
study in Table 1. Finally, we simulate the corresponding times to event
using a proportional hazards model (parametric bootstrap) fitted to the
j-th dataset:
Mjtrue : 
j tjxð Þ=j0 tð Þ  exp xTj
 
; ð1Þ
where j(tjx) is the individual hazard function when the vector of pre-
dictors is equal to x and j denotes a vector of regression coefficients. We
combine the truncated inversion method in Bender et al. (2005) and the
Nelson–Aalen estimator for cumulative hazard functions to simulate sur-
vival times that reflect survival distributions and follow-up of the real
studies. We set the vector j to be the coefficients fitted in study j=1, . . . ,
I using the CoxBoostmethod (Binder and Schumacher, 2008). A different
regression method could have been used at this stage. The collections of
simulated datasets are then used both (i) to compute by Monte-Carlo
method the true global ranking defined in Section 2.5, and (ii) to compute
ranking estimates through CV and CSV. Figure 1A displays, for each pair
of studies (i, j) in Table 1, the C-index obtained when training a model by
Ridge regression on dataset i (rows), and validating that model on dataset
j (columns). We computed the diagonal elements (i= j) by 4-fold CV.
Figure 1B displays mean C-indices for each (i, j) combination across
simulations, when the training and validation studies are generated
resampling the i-th and j-th study. Here diagonal elements are computed
by averaging C-indices with the training and validation datasets inde-
pendently generated by resampling from the same study.
The strong similarity between the two panels is reassuring, in particular
with regard to the clear separation of the eight studies into two groups.
The first group includes studies MNZ, ST1, ST2, TRP, UNT and VDX,
and produces more accurate prediction models than the remaining stu-
dies. The datasets in this group are also associated with higher values of
the concordance index when used for validation. This difference between
the two groups is also illustrated in Figure 1C. It displays the non-diag-
onal entries of the matrices represented in the left and middle panels, that
is the average C-indices from simulated datasets, against the C-indices
from real data. This scatterplot shows a clear two-cluster structure: the
yellow dots display the 30 training and validation combinations within
studies MNZ, ST1, ST2, TRP, UNT and VDX. We will return to this
cluster structure in the discussion.
2.8 Evaluation criteria for simulations
In simulation studies we can assess and rank algorithms based on their
ability to recover the true underlying models Mitrue; i=1; . . . ; I: In this
subsection, we introduce a criterion that reflects the degree of similar-
ity between the true regression coefficients i that were used to
simulate the i-th in silico dataset and the coefficients bðkÞj fitted through
algorithm k on the j-th simulated dataset. We consider the i= j and i 6¼ j
cases separately. Similarity between vectors is usually quantified by com-
puting the Euclidean distance between them. However, since our focus is
on prediction, we usecorðXii;XibðkÞj Þ; the correlation between true and estimated patient-
specific prognostic scores, to measure the similarity between the true i
and estimated regression coefficients bðkÞj : Here Xi is the matrix of pre-
dictors of dataset i and cor denotes Pearson’s correlation. The average
Skself= 1=Ið Þ 
X
i
cor Xii;Xib kð Þi
 
; ð2Þ
over the I studies, provides a measure of the ability of learning algorithm
k to recover the model that has generated the training dataset, hence the
index self.
Another criterion of interest is the ability of a learning algorithm k to
recover the vector of regression coefficients i when it is trained on a
separate dateset j 6¼ i and the unknown models underlying datasets i and j
might differ from each other.
This can be quantified with
Skacross= 1= I I 1ð Þð Þð Þ 
X
i
X
j6¼i
cor Xii;Xib kð Þj
 
; ð3Þ
where the index across emphasizes the focus on cross-study similarity, i.e.
on the ability of algorithm k to recover the coefficients i when fitted on
dataset j, with j 6¼ i:
In alternative to averaging across studies, or pairs of datasets, as in
Equations (2–3) one can also use different summaries, e.g. quantiles, as
we do in Section 2.4. Both Skself and S
k
across are summary statistics to assess
and compare learning algorithms. We denote the ranking obtained by
ordering the algorithms according to Sself(Sacross) by Rself(Racross). Both
Skself and S
k
across vary across simulations of the datasets ensembles, al-
though the hierarchical simulation model remains fixed and their com-
putations involve the vectors i, i=1, . . . , I. We will therefore call the
rankings Rself and Racross local because they are specific to the collection
of datasets at hand.
3 RESULTS
3.1 Simulated data
Our focus in the simulation study is on differences between the
rankings and performance estimates obtained by using CV and
CSV. We will use CV and CSV to denote the means of the
diagonal and non-diagonal elements of a CSV matrix, respect-
ively. Recall that we compute the diagonal elements through CV.
Figure 2A shows, for K=6 algorithms, the distributions of
CSV and CV; and Figure 2B shows the distribution of the rank-
ings estimates, across 1000 simulated collections of eight data-
sets. Table 2 compares the medians of the distributions in
Figure 2B with the true global rankings that we obtained using
the criteria in Section 2.4. The rank of method k is 1 if it
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outperforms the remaining K – 1 training algorithms. We ob-
serve large differences in the distributions of CSV and CV across
simulations (Fig. 1A): the average of the CV scores, under all the
algorithms we considered, is close to 0.65, while the CSV scores
are centered at 0.55. The variability of CV and CSV across
simulations, however, is comparable.
Performance differences across algorithms, whether estimated
by CV or CSV, are relatively small compared to the overall dif-
ference between CV and CSV performance estimates. We also
observe differences between the rank distributions produced by
CV and CSV. Accordingly, to both CV and CSV, in most of the
simulations, Lasso regression is ranked as one of the worst per-
forming algorithms, while Ridge regression and Plusminus are
ranked first or second. However, the CV summaries suggest an
advantage of Ridge regression over Plusminus across most of the
simulations while CSV rank Plusminus as the best performing
algorithm in 50% of the simulations. The median rank of
CoxBoost across simulations has an improvement of two pos-
itions when it is estimated through CV and compared to the CSV
summaries; in this case CSV results are more consistent with the
true global rankings (Table 2). When we consider the criteria
described in Section 2.4, Ridge regression and Plusminus ex-
change the top-two positions of the true global rankings (see
Table 2), although for these two algorithms the Zi,j distributions
under our simulation scenario are nearly identical.
The local rankings Racross and Rself of the K=6 algorithms
defined by Skacross and S
k
self in Section 2.8 vary across the 1000
simulated collections of studies. The median Kendall’s correl-
ation between Racross and Rself across simulations is 0.5, i.e.
the performance measures Skacross and S
k
self tend to define distinct
rankings of the competing algorithms, see also the
Supplementary Figure S1. We illustrate the extent to which CV
and CSV recover the unknown rankings Racross and Rself. The
boxplots in Figure 3 display the Kendall’s correlation between
local rankings (i) Racross or(ii) Rself , and the rankings estimated
through CV (gray boxes) and CSV (white boxes) across simula-
tions. Figure 3C shows the Kendall’s correlation between the
true global ranking and the ranking estimates. The median
Kendall’s correlation between Rself and the corresponding CSV
estimates across simulations is 0.5. The CV ranking estimates
tend to be less correlated with the local rankings Racross than the
CSV estimates. In contrast, the CV estimates tend to be more
correlated with Rself than the CSV estimates. We recall that both
CV and Rself are defined summarizing performance measures,
Zki;i and corðXii;XibðkÞi Þ; that refer to a single study, while
CSV and Racross summarizes performance measures computed
using two distinct studies that are used for training and
validation.
Finally, CSV tends to be more correlated with the true global
ranking than CV. This suggests that CSV is more suitable for
recovering the true global ranking. When we removed the two
outlier studies (CAL and MSK) and repeated the simulation
study, the advantage of CSV over CV in recovering the true
global ranking was confirmed (median Kendall’s correlation
0.8 versus 0.6, see also Supplementary Figs S2–S4), moreover
after their removal Kendall’s correlations between Rself and the
CSV estimates tend to be larger than those between Rself and the
CV estimates. Overall, as displayed by the Supplementary Figure
S3, it appears that, after outlier studies are removed, CSV out-
performs substantially CV when used for ranking algorithms.
3.2 Application to breast cancer prognostic modeling
We apply CV and CSV to the I=8 breast cancer studies
described in Section 2. Generally, the results resemble those ob-
tained on simulated data. The top panel in Figure 4 illustrates the
distributions of the diagonal and off-diagonal validation statis-
tics in Zk for each of the K=6 algorithms. Except for the dis-
tinctly larger interquartile ranges of the box-plots we observe
several similarities with Figure 2. Note that each box-plot
A
B
Fig. 2. Comparison of CSV and CV on simulated data. Each panel rep-
resents evaluations of K=6 algorithms across 1000 simulations of a
compendium of I=8 datasets. For each simulation the diagonal or
off-diagonal elements of the Zk matrix of validation C-statistics is sum-
marized by (A) mean and (B) rank of the mean across algorithms. CV
estimates tend to be much higher than the CSV estimates. In most of the
simulations Lasso is ranked as one of the worst algorithms, both by CV
and CSV, while Ridge and Plusminus are ranked among the best predic-
tion methods
Table 2. True global rankings and estimates with CV and CSV on
simulated data
Algorithm Global
true ranking
CSV
(median ranks)
CV
(median ranks)
Criterion Average Medium Average Medium Average Medium
Ridge 1 2 2 2 1 2
Plusminus 2 1 2 2 2 2
Superpc 3 3 4 3 4 4
Unicox 4 4 4 4 5 4
CoxBoost 5 5 5 5 3 4
Lasso 6 6 6 6 5 6
Median estimates across 1000 simulations are displayed for CV and CSV; individual
columns refer to summarization of the Zki;j statistics by using the mean or the
median as discussed in Section 2.4. We also computed the true global ranking as
well as CV and CSV estimates by using the third quartile of the Zki;j summaries, and
obtained results identical to those displayed for the rankings obtained by summar-
izing validation results through their median. Both CV and CSV tend to rank Ridge
regression and Plusminus as best performing algorithms. Variability of CV and CSV
rank estimates across simulations is shown in Figure 2B.
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represents validation scores within a single Zk-matrix, whereas in
Figure 2 each box-plot displays a summary of 1000 Zk matrices,
one for each simulation. This explains the higher variance
observed in Figure 4. We also observe the following.
 CV estimates are 0.06 higher than CSV estimates on the
C-index scale. To interpret the magnitude of this shift on the
C-index scale consider a population with two groups of pa-
tients, high and low risk patients, covering identical propor-
tions 0.5 of the population. A perfect discrimination model
that correctly recognizes the subpopulation of each individ-
ual, when the hazard ratio between high versus low risk
patients is 2.7, achieves on average a C-index of 0.62. It is
necessary to double the hazard ratio to 5.4 to increase the
average C-index of the perfect discrimination model to 0.68.
Thus, it is fair to say that the CV results are considerably
more optimistic than the CSV estimates.
 The ranking defined by CSV, using median summaries of
the Zki;j scores, is nearly identical to the global ranking in our
simulation example (see Supplementary Table ST1 and
Table 2). With both, median and third quartile aggregation
of the Zki;j statistics, the rankings defined by CV and CSV
differ substantially (Kendall’s correlations 0.6 and 0.07).
This is consistent with the results of the simulation study,
where median correlation of the rankings estimated through
CSV and CV was 0.4 (see Supplementary Fig. S1).
 The presence of outlier studies (CAL and MSK) has a
strong effect on the ranking estimates when we use the
mean to summarize the Zk matrices. After aggregating the
validation statistics by averaging, both CSV and CV rank
Superpc first. This result might be due to the high variability,
0.5, of the Zki;j validation scores corresponding to models
trained by outlier studies. In particular, Superpc and Unicox
are the only algorithms that produce models with substantial
prediction performances when trained on the MSK study.
With median summarization the ranking estimates are less
influenced by the presence or absence of outlier studies. We
therefore recommend the use of the median to summarize Zk
matrices.
 Figure 4B illustrates lack of agreement between CSV and
CV performance estimates. The black digits contrast, for
each dataset i, the CSV summary
X
j 6¼i ðI 1Þ
1Zki;j versus
the CV summary Zki;i: Performance measures refer to Ridge
regression. Similarly, the gray digits in this panel contrastX
j 6¼i ðI 1Þ
1Zkj;i with Z
k
i;i: The CV performance
statistics Zki;i are only moderately correlated with the
CSV statistics
X
j 6¼i ðI 1Þ
1Zki;j (correlation=0.2), and
negatively correlated with the CSV summariesX
j 6¼i ðI 1Þ
1Zkj;i (correlation=–0.33).
3.3 CV and CSV summaries
Correlation between CSV and CV summary statistics, as dis-
played in Figure 4B, suggests that cross- and within-study per-
formances are less redundant than one might expect. In
Figure 4B study specific CSV summaries are plotted against
CV for Ridge regression. For each study we have a single CV
statistic and two CSV statistics obtained by averaging the
A
B
Fig. 4. Panel (A) describes the CSV and CV statistics in Zk, separately for
each of the six algorithms that we considered. Each box-plot represents
the variability of CV or CSV performance statistics from a single Zk
matrix. The CV statistics tend to be higher than the CSV statistics.
Panel (B) contrasts with black digits, for each study i, the CSV summaryX
j6¼i ðI 1Þ
1Zki;j with the CV summary Z
k
i;i: Similarly, with gray digits
it contrasts the CSV summary
X
j 6¼i ðI 1Þ
1Zkj;i with the CV summary
Zki;i: This panel shows results for the learning algorithm Ridge regression
and the displayed numbers refer to Table 1 (outliers CAL and MSK were
removed). Cross-validation statistics on the y-axis are moderately corre-
lated to the CSV summaries on the x-axis; identical considerations hold
for all K=6 algorithms that we used
A B C
Fig. 3. Kendall’s correlation between true global or local rankings and
estimates obtained with CSV (white box-plots) or CV (cross-validation,
gray box-plots) across simulations. Panels (A) and (B) compare CV and
CSV in terms of their correlation to the local rankings (Racross and Rself),
while panel (C) considers the true global ranking. Each box-plot repre-
sents a correlation coefficient that was computed in each of the 1000
iterations of our simulation study. CSV tend to achieve a higher correl-
ation with the global ranking and Racross than CV. The results displayed
have been computed using the mean criterion discussed in Section 2.4
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Z-matrix column- and row-wise. In the column-wise case correl-
ations, between CSV and CV summaries, vary across algorithms
0.5, while in the row-wise case all the correlations are negative.
Overall, we can consider cross- and within-study prediction as
two related but distinct problems.
We also noted that CV is less suitable for detection of outlier
studies than CSV; in particular CV can estimate encouraging
prediction performances even on studies associated, under each
training algorithm, with poor CSV summaries Zki;i: For instance,
with the SuperPC algorithm all but one C-index estimates ob-
tained with CV are above 0.6.
3.4 Specialist and generalist algorithms
Our analyses lead to the question of whether some algorithms
can be considered as generalist or specialist procedures according
to our definitions. Our examples are not exhaustive and add-
itional comparisons, within the development of new prognostic
models, are necessary in order to determine ‘specialist’ or ‘gen-
eralist’ tendencies of these algorithms. However, the fact that
Ridge regression, Lasso regression and CoxBoost are ranked dis-
tinctly better accordingly to CV than CSV, in most iterations of
our simulation study, suggests that these algorithms might be
specialist procedures and adapt to the specific properties of the
individual dataset. The status of generalist versus specialist, for
each algorithm, can be discussed using the local performance
criteria Sself and Sacross, which are conceived to measure
within-single-studies and generalizable prediction performances.
We note that CoxBoost and Ridge regression tend to achieve
better ranks in Rself than in Racross. In particular CoxBoost im-
proves its position by 1 or 2 ranks in most simulations, which is
similar to what we observed comparing CoxBoost’s CSV and CV
rankings. In summary, in our study, these two algorithms seem
to have—accordingly to all the criteria that we considered—a
tendency to specialize to the dataset at hand. We mention that,
as one can expect, for all the algorithms Sself is consistently
higher than Sacross. We also compared CV to independent
within-study validation using our simulation model. For the inde-
pendent within-study validation, we iteratively pair two datasets
generated using identical regression coefficients and gene expres-
sion distributions. Subsequently, we train a model on the first
dataset and evaluate it on the second one. As can be seen in
Supplementary Figure S5, CV values, as expected, are slightly
smaller than for the independent within-study validations.
4 DISCUSSION AND CONCLUSION
In applying genomics to clinical problems, it is rarely safe to
assume that the studies in a research environment faithfully rep-
resent what will be encountered in clinical application, across a
variety of populations and medical environments. From this
standpoint, study heterogeneity can be a strength, as it allows
to quantify the degree of generalizability of results, and to inves-
tigate the sources of the heterogeneity. This aspect has long been
recognized in meta-analysis of clinical trials (Moher and Olkin,
1995). Therefore, we expect that an increased focus on quantify-
ing cross-study performance of prediction algorithms will con-
tribute to the successful implementation of the personalized
medicine paradigm.
In this article we provide a conceptual framework, statistical
approaches and software tools for this quantification. The con-
ceptual framework is based on the long-standing idea that finite
populations of interest can be viewed as samples from an infinite
‘super-population’ (Hartley and Sielken, 1975). This concept is
especially relevant for heterogeneous clinical studies originating
from hospitals that sample local populations, but where re-
searchers hope to make generalizations to other populations.
As an illustrating example, we demonstrate CSV on eight in-
dependent microarray studies of ER-positive breast cancer, with
metastasis-free survival as the endpoint of interest. We also de-
velop a simulation procedure involving two levels of non-
parametric bootstrap (sampling of studies and sampling of ob-
servations within studies) in combination with parametric boot-
strap, to simulate a compendium of independent datasets with
characteristics of predictor variables, censoring, baseline hazards,
prediction accuracy and between-dataset heterogeneity realistic-
ally based on available experimental datasets.
Cross-validation is the dominant paradigm for assessment of
prediction performance and comparison of prediction algorithms.
The perils of inflated prediction-accuracy estimations by incor-
rectly or incompletely performed cross-validation are well
known (Molinaro et al., 2005; Subramanian and Simon, 2010;
Simon et al., 2011; Varma and Simon, 2006). However, we
show that even strictly performed cross-validation can provide
optimistic estimates relative to CSV performance. All algorithms,
in simulation and example, showed distinctly decreased perform-
ance in CSV compared to cross-validation. Although it would be
possible to further reduce between-study heterogeneity, for ex-
ample by stricter filtering on clinical prognostic factors, we believe
this degree of heterogeneity reflects the reality of clinical genomic
studies and likely other applications. Some sources of biological
heterogeneity are unknown, and it is impossible to ensure consist-
ent application of new technologies in laboratory settings.
Prediction models are used in presence of unknown sources of
variation. Formal CSV provides a means to assess the impact of
unknown or unobserved confounders that vary across studies.
In simulations, the ranking of algorithms by CSV was closer to
the true rankings defined by cross-study prediction, both when
we considered Racross and the global true ranking. Surprisingly,
CSV was also competitive with CV for recovering true rankings
based on within-study prediction, such as Rself. Although the
performance differences we observed between algorithms were
smaller than the difference between CV and CSV, Lasso consist-
ently compared poorly with most of the competing algorithms,
both under CV and CSV evaluations. Lasso, and other algo-
rithms that ensure sparsity have been shown to guarantee poor
prediction performances in previous comparative studies
(Bøvelstad et al., 2007; Waldron et al., 2011).
Systematic CSV provides a means to identify relevant sources
of heterogeneity within the context of the prediction problem of
interest. By simple inspection of the CSV matrix we identified
two outlier studies that yielded prediction models no better than
random guessing in new studies. This may be related to known
differences in these studies: smaller numbers of observations,
higher proportions of node positive patients, different treatments
and larger tumors (Supplementary Figs S6–S9). Conversely,
other known between-study differences do not seem to have
created outlier studies or clusters of studies as seen in the Z
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matrix, such as between studies where all or no patients received
hormonal treatment. We note that incorporation of clinical prog-
nostic factors into genomic prognostic models could likely pro-
duce gains in CSV accuracy, and that such multi-factor
prognostic models could also be assessed by the proposed
matrix of CSV statistics.
In practice it is neither possible nor desirable to eliminate all
sources of heterogeneity between studies and between patient
populations. The adoption of ‘leave-one-in’ CSV, in settings
where at least two comparable independent datasets are available,
can provide more realistic expectations of future prediction model
performance, identify outlying studies or clusters of studies, and
help to develop ‘generalist’ prediction algorithms whichwill hope-
fully be less prone to fit to dataset-specific characteristics. Further
work is needed to formalize the identification of clusters of com-
parable studies, to develop databases for large-scale cross-study
assessment of prediction algorithms, and to develop better ‘gen-
eralist’ prediction algorithms. Appropriate curated genomic data
resources are available in Bioconductor (Gentleman et al., 2004)
through the curatedCRCData, curatedBladderData and
curatedOvarianData (Ganzfried et al., 2013) packages, and in
other common cancer types through InSilicoDB (Taminau
et al., 2011). In realms where such curated resources are available,
CSV is in practice no more difficult or CPU-consuming than
cross-validation, and should become an equally standard tool
for assessment of prediction models and algorithms.
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